Frontlight ResearchEarly access
CompletedNo phase
Performance of Two Sclera Fixated Intraocular Lens Concepts
Key facts
- Who runs it
- Johannes Kepler University of Linz
- Where
- Austria1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 26 people enrolled
- Started
- 19 Jan 2023
- Ended
- 30 Jan 2024
- Type of study
- Observational, 2 groups
- Treatments tested
- IOL Master 700
- Casia-2
- MS-39
- OSIRIS
- Autorefractor
- Subjective Refraction
- Record updated
- 8 March 2024
Who can take part
- Age
- 21 years to 110 years
- Sex
- Women and men
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- minimum age of 21 years
- planned surgery or already taken place surgery using a scleral fixated lens
Who cannot take part
- best corrected visual acuity <0.05 Snellen
- pregnancy
- missing informed consent form
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To evaluate and compare the post-operative outcome of two different sceral fixated IOL concepts, the Yamane method (ZA9003, J\&J, USA) and the Carlevale IOL (FIL-SSF, Soleko, Italy).
The 2 groups in the trial
- Carlevale
Patients who had a Carlevale lens implanted
Treatment: IOL Master 700, Casia-2, MS-39, OSIRIS, Autorefractor, and Subjective Refraction
- Yamane
Patients who had a lens implanted using Yamane technique
Treatment: IOL Master 700, Casia-2, MS-39, OSIRIS, Autorefractor, and Subjective Refraction
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 8 March 2024